Is a Blood Clot in the Spleen Dangerous?

A blood clot that cuts off blood flow to the spleen can absolutely be dangerous, though the severity depends on how much tissue is affected, what caused the clot, and whether complications develop. The medical term for this is splenic infarction, and it ranges from a small area of damage that heals on its own to a life-threatening event requiring emergency surgery. What makes splenic clots especially tricky is that the clot itself is rarely the whole story; it usually signals a deeper underlying condition, and the danger often lies as much in that root cause as in the clot.

What Actually Happens Inside the Spleen

The spleen is a fist-sized organ tucked under your left ribcage. It filters old or damaged red blood cells, stores platelets, and plays a significant role in immune defense. Like any organ, it depends on a steady supply of blood. When a clot blocks one of the arteries feeding the spleen, the tissue downstream is starved of oxygen and begins to die. This is splenic infarction: tissue death caused by interrupted blood flow.¹ The blockage can come from an embolus (a clot that traveled from somewhere else, like the heart) or from a clot that formed directly in a splenic vessel.²

If only a small branch of the artery is blocked, you might lose a wedge-shaped section of spleen tissue. This can hurt and be unpleasant, but the remaining spleen picks up the slack. If a larger vessel is involved, the infarction can affect most of the organ. That is when things get more serious: the risk of complications rises, more aggressive treatment becomes necessary, and the damage to your immune defenses may be lasting.

Why Blood Clots Form in the Spleen

Splenic infarction is uncommon, but it doesn’t appear out of nowhere. It almost always points to an underlying condition. A large retrospective study of over 240 cases found that the most common cause was cancer, accounting for about 36% of cases, followed by severe infections at 31%, a cardiac source of emboli at 27%, and recent abdominal surgery at 18%.² A separate multicenter study found that atrial fibrillation was the single most common predisposing condition, with infective endocarditis (an infection of the heart valves) close behind.³

These two causes reflect different mechanisms. With atrial fibrillation, the heart beats irregularly, which lets blood pool and form clots inside the heart chambers. Those clots can break free and travel through the bloodstream until they lodge in a smaller vessel, and the spleen’s arteries are one possible landing site. With endocarditis, bacteria growing on a heart valve create small infected clumps that shed into the bloodstream. When those clumps reach the spleen, they cause both a blockage and an infection simultaneously, which is a particularly dangerous combination.

Blood disorders are another major driver. Conditions that make the blood thicker or more prone to clotting raise the risk substantially. In polycythemia vera, for instance, the body produces too many red blood cells, and the lifetime risk of a clotting event is estimated at roughly 20% to 30%.¹ Antiphospholipid syndrome, an autoimmune condition that creates a persistent tendency toward clotting, can cause recurrent splenic infarctions, sometimes even in patients already on blood thinners.⁴

Less common causes round out the picture. Certain viral infections can occasionally trigger splenic infarction even in otherwise healthy people. Epstein-Barr virus, the virus behind mononucleosis, has been documented as a rare but real cause, typically in young adults who develop swollen spleens during the infection.⁵

How You Might Know Something Is Wrong

The classic symptom is sudden, sharp pain in the upper left part of your abdomen, sometimes radiating to the left shoulder. Nausea, vomiting, and fever can accompany it. The trouble is that these symptoms overlap with many other conditions: a kidney stone, pancreatitis, a pulled muscle, even gas pain. Smaller infarctions sometimes produce no symptoms at all and are discovered incidentally on imaging done for another reason.

The standard diagnostic tool is a contrast-enhanced CT scan. On these images, a splenic infarction typically appears as a wedge-shaped area that doesn’t light up the way healthy tissue does, with the wide end pointing toward the outer surface of the spleen.⁶ Early on, the borders of the damaged area may look blurry; over time, they sharpen as the body walls off the dead tissue. Doctors also use the CT to check for complications like fluid collections, abscesses, or signs that the spleen might be rupturing.

When Complications Make Things Worse

Most small splenic infarctions heal without major trouble. The dead tissue gradually gets reabsorbed, sometimes leaving behind a scar or a small fluid-filled pocket. The real danger arises when complications develop. These include abscess formation, hemorrhage, and in the most severe cases, rupture of the spleen. Though individually uncommon, any of these can become life-threatening, and splenectomy (surgical removal of the spleen) may be needed when internal bleeding or sepsis occurs.³

Abscess formation is a feared complication because a pocket of dead tissue can become a breeding ground for bacteria. Infarcted tissue that becomes infected can progress to a splenic abscess, which in turn can lead to sepsis if bacteria enter the bloodstream.⁷ This is especially concerning in patients whose clot originated from an infected source like endocarditis, because bacteria are already present in the material that caused the blockage.

The underlying cause also affects how dangerous the infarction turns out to be. The multicenter study mentioned earlier found that patients whose splenic infarction was caused by infective endocarditis were admitted to the ICU at a strikingly high rate of about 62%, compared to roughly 19% for patients whose infarction stemmed from atrial fibrillation.³ The clot in the spleen may be the same size in both scenarios, but the systemic infection driving it in endocarditis makes the overall situation far more precarious.

How Splenic Clots Are Treated

Treatment depends heavily on what caused the clot and how severe the damage is. For many patients, the approach is conservative: pain management, close monitoring, and treatment of the underlying condition. If the infarction resulted from atrial fibrillation, for instance, controlling the heart rhythm and starting anticoagulation to prevent further clots are the priorities.

Anticoagulant therapy, or blood-thinning medication, plays a central role. A multicenter study found that patients with splenic infarction who received anticoagulants had dramatically better long-term survival compared to those who did not.⁸ This makes intuitive sense: if a clot reached the spleen, the same underlying clotting tendency can send clots to the brain, lungs, or kidneys next. Blood thinners address that systemic risk, not just the splenic event. The same study found no significant increase in bleeding events among the anticoagulant group, which is reassuring given the obvious concern about thinning the blood near an already-damaged organ.

Surgery enters the picture when complications demand it. If the spleen ruptures, if a large abscess won’t respond to antibiotics and drainage, or if the spleen is essentially destroyed, removal may be unavoidable. Splenectomy is effective at resolving the immediate crisis, but it introduces its own long-term consequences, which are significant enough to deserve their own discussion.

Living Without a Spleen

The spleen’s immune role means that removing it comes at a cost. Doctors generally try to preserve the spleen when they can, but sometimes the damage is too extensive or the complications too severe to allow it. The most widely recognized long-term risk after splenectomy is overwhelming bacterial infection, where certain encapsulated bacteria that the spleen normally helps clear can cause rapidly fatal sepsis.⁹

A large cohort study following over 8,000 patients for up to 27 years found that people who had their spleens removed had about double the risk of pneumonia, roughly two and a half times the risk of meningitis, and more than triple the risk of blood-poisoning infections compared to matched controls. These elevated risks persisted even more than a decade after the surgery.¹⁰ Those numbers aren’t a reason to panic: the absolute risk of these infections in any given year is still low. But they are persistent, and they mean that someone without a spleen needs to stay current on vaccinations against pneumococcal bacteria and meningitis, carry information about their spleen status, and treat any fever as potentially urgent.¹¹

Beyond infection, thrombosis itself is increasingly recognized as another complication of splenectomy. The spleen normally removes old platelets from circulation, and without it, platelet counts can rise, making the blood stickier and more prone to clotting.⁹ This creates an ironic situation: removing the spleen to deal with a clot-related problem can potentially increase the risk of future clots elsewhere.

When Only Part of the Spleen Is Saved

Because of these long-term risks, there is growing interest in preserving as much splenic tissue as possible. Partial splenectomy, repair of the damaged portion, or blocking blood flow to just the affected area through embolization are all strategies that aim to stop the immediate problem while keeping some functioning spleen in place. Studies comparing patients who had their spleens completely removed to those who had preservation procedures suggest that immune function can remain at least partially intact when some splenic tissue survives, though the evidence is still evolving.¹²

One study comparing total splenectomy patients to those who had preservation treatment found that key immune markers, including antibody levels against pneumococcal bacteria, were not significantly different between the two groups. However, some blood markers did differ: patients who lost their entire spleen had higher platelet counts and showed other signs consistent with absent splenic function.¹³ The practical takeaway is that while preservation sounds preferable on paper, the immune benefit over total removal is still not firmly established. The decision depends on the specific clinical situation and the surgeon’s judgment about what the damaged spleen can tolerate.

Splenic Vein Thrombosis Is a Different Problem

It’s worth distinguishing splenic infarction from splenic vein thrombosis, because both involve clots related to the spleen, and both show up when people search for information on blood clots in the spleen. But they are different conditions with different causes and different risks.

In splenic infarction, the blockage is in the artery bringing blood to the spleen. In splenic vein thrombosis, the clot is in the vein draining blood away from the spleen. The most common cause of splenic vein thrombosis is pancreatitis: inflammation from the pancreas, which sits right next to the splenic vein, irritates the vein wall and triggers clot formation.¹⁴ A meta-analysis estimated that about 14% of all pancreatitis patients develop this complication, with the rate climbing to roughly 23% in patients with acute pancreatitis.¹⁵

The danger here is different from infarction. When the vein draining the spleen is blocked, blood has to find alternative routes. It gets rerouted through smaller vessels, including veins near the stomach, which can swell into varices (abnormally enlarged veins). These gastric varices are fragile and can rupture, causing sudden and severe gastrointestinal bleeding. In one documented case, a patient developed gastric variceal bleeding years after a bout of pancreatitis, illustrating how splenic vein thrombosis can create problems long after the initial event that caused it.¹⁶

What Puts People at Greatest Risk of a Bad Outcome

Not all splenic clots carry the same danger, and several factors tilt the odds. The multicenter study on long-term mortality after splenic infarction identified prior stroke and liver cirrhosis as the strongest predictors of dying. Prior stroke carried over thirteen times the mortality risk, and cirrhosis roughly nine times the risk.⁸ Both of these make sense in context: a prior stroke signals advanced vascular disease with clotting tendencies that threaten multiple organs, and cirrhosis disrupts the body’s clotting balance in complex ways while also impairing the liver’s ability to clear toxins and fight infection.

On the flip side, people whose splenic infarction is an isolated event caused by something treatable, like a single episode of atrial fibrillation that gets properly managed, tend to recover well. The spleen has some regenerative capacity, and the body can compensate for modest losses of splenic tissue without obvious immune deficits. For these patients, the most important thing is addressing the underlying clotting risk so the same thing doesn’t happen in a more critical organ like the brain or heart.

Young, otherwise healthy individuals who develop a splenic infarction from a rare cause like a viral infection or a previously unknown clotting disorder generally have the best prognosis. Their main challenge is the diagnostic workup: figuring out why a clot formed in the first place, so that future events can be prevented. In some autoimmune clotting conditions like antiphospholipid syndrome, that may mean lifelong anticoagulation, a serious commitment but one that substantially reduces the risk of recurrence.⁴

1
PubMed Central. Splenic infarction secondary to polycythemia Vera: Case report and literature review
2
Thrombosis Update. Treatment, thrombosis, and bleeding in patients with splenic infarcts
3
Scientific Reports. Risk assessment and prognostic analysis of patients with splenic infarction in emergency department: a multicenter retrospective study
4
Blood. Recurrent splenic infarction in triple-positive antiphospholipid syndrome despite therapeutic anticoagulation
5
PubMed Central. Splenic Infarcts in an Adult Male with Epstein-Barr Virus Infection: A Rare Complication
6
PubMed Central. Computed tomography of the spleen: how to interpret the hypodense lesion
7
European Journal of Internal Medicine. Splenic infarct is a plausible alternative diagnosis in suspected splenic abscess
8
PubMed Central. Anticoagulant Therapy Is Associated With Decreased Long-Term Mortality in Splenic Infarction Patients: A Multicenter Study
9
PubMed Central. Vascular complications after splenectomy for hematologic disorders
10
Haematologica. Long-term risks after splenectomy among 8,149 cancer-free American veterans: a cohort study with up to 27 years follow-up
11
PubMed. Medical complications following splenectomy
12
PubMed. Non-operative management and immune function after splenic injury
13
PubMed. Does splenic preservation treatment (embolization, splenorrhaphy, and partial splenectomy) improve immunologic function and long-term prognosis after splenic injury?
14
PubMed Central. Acute Pancreatitis Induced Splenic Vein Thrombosis
15
PubMed Central. Natural history of pancreatitis-induced splenic vein thrombosis: a systematic review and meta-analysis of its incidence and rate of gastrointestinal bleeding
16
PubMed Central. Gastric variceal bleeding due to pancreatitis-induced splenic vein thrombosis